Dr. John H. Vu
Claim this profileBaptist MD Anderson Cancer Center
Area of expertise
Lung Cancer
John H. Vu has run 4 trials for Lung Cancer. Some of their research focus areas include:
Non-Small Cell Lung Cancer
John H. Vu has run 3 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
Baptist MD Anderson Cancer Center
Clinical Trials John H. Vu is currently running
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting
2 awards
Phase 3
28 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting
2 awards
Phase 3
27 criteria
More about John H. Vu
Clinical Trial Related
11 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments John H. Vu has experience with
- Paclitaxel
- Gemcitabine Hydrochloride
- Nivolumab
- Ipilimumab
- Durvalumab
- Biospecimen Collection
Breakdown of trials John H. Vu has run
Lung Cancer
Non-Small Cell Lung Cancer
Anaplastic Large Cell Lymphoma
ALK Gene Rearrangement
Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does John H. Vu specialize in?
John H. Vu focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage II.
Is John H. Vu currently recruiting for clinical trials?
Yes, John H. Vu is currently recruiting for 2 clinical trials in Jacksonville Florida. If you're interested in participating, you should apply.
Are there any treatments that John H. Vu has studied deeply?
Yes, John H. Vu has studied treatments such as Paclitaxel, Gemcitabine Hydrochloride, Nivolumab.
What is the best way to schedule an appointment with John H. Vu?
Apply for one of the trials that John H. Vu is conducting.
What is the office address of John H. Vu?
The office of John H. Vu is located at: Baptist MD Anderson Cancer Center, Jacksonville, Florida 32207 United States. This is the address for their practice at the Baptist MD Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.